The Journal of Clinical Endocrinology & Metabolism · 2015 · 43 citations · 7 references
MedicineEndocrinologyPediatricsAutoimmunityImmunopathologyPediatric EndocrinologyAutoimmune DiseasesAutoimmune EndocrinopathiesAutoimmune Skin DiseasesJuvenile DermatomyositisLipid Metabolism DisordersMetabolic SyndromeAutoimmune Hepatitis TreatmentDermatomyositis Skin DiseaseHepatic Insulin ResistanceLeptin ResistanceLeptin SignalingPediatric Autoimmune Hepatitis
CONTEXT: Acquired generalized lipodystrophy (AGL) is associated with leptin deficiency as a result of adipose tissue loss and hypertriglyceridemia, insulin resistance, and hepatic steatosis. It may coexist with other autoimmune diseases such as Hashimoto's thyroiditis, rheumatoid arthritis, hemolytic anemia, and chronic active hepatitis. Metreleptin therapy has been shown to improve metabolic abnormalities in lipodystrophy, but the effect on AGL patients with active autoimmune disease is unknown. CASE DESCRIPTION: We report 3 cases of pediatric patients with AGL and distinct active autoimmune diseases who were treated with metreleptin over a period of 4-6 years. Case 1 is a 9-year-old girl with active juvenile dermatomyositis, who was successfully treated with leptin with no worsening of her dermatomoysitis. Case 2 is a 16-year-old female with Graves' disease, who could discontinue all her antidiabetic medication completely with improved triglyceride levels. Case 3 is an 11-year-old boy with active autoimmune hepatitis and chronic urticaria, whose hyperphagia has resolved and his liver enzymes and hepatosplenomegaly have improved. CONCLUSION: Metreleptin therapy is of considerable clinical benefit to reduce insulin resistance and hypertriglyceridemia and did not appear to alter the clinical course of autoimmune disease nor clinical efficacy of immunosuppressive treatments. Our observations suggest that risk or presence of autoimmune disease should not lead to withholding of metreleptin treatment from patients with AGL, but should prompt close clinical follow up in light of cautionary preclinical data.
7
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Graham M. Lord, Giuseppe Matarese, Jane K. Howard et al. · Nature · 1998 · 2.2K citations
Leptin-Replacement Therapy for Lipodystrophy
Elif A Oral, Vinaya Simha, Elaine Ruiz et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text
Leptin Accelerates Autoimmune Diabetes in Female NOD Mice
Giuseppe Matarese, Veronica Sanna, Robert I. Lechler et al. · Diabetes · 2002 · 198 citations · Full text
Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
Rachel J. Perry, Xian‐Man Zhang, Dongyan Zhang et al. · Nature Medicine · 2014 · 187 citations
Medicine, Endocrinology, Physiology +12